Chifeng Wanze Pharmaceutical

Wanze Biopharmaceutical, formerly known as Chifeng Wanze Pharmaceutical, is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of micro-ecological preparations and probiotics. The company is best known for its flagship product, Jinshuangqi (Bifidobacterium infantis, Lactobacillus acidophilus, and Enterococcus faecalis tablets), which is widely used in China to treat intestinal flora imbalance and related gastrointestinal disorders. Operating as a key subsidiary of the Wanze Group, the company maintains large-scale GMP-certified manufacturing facilities in Chifeng, Inner Mongolia. Its business model focuses on the commercialization of live biotherapeutic products for both pediatric and adult populations suffering from diarrhea, constipation, and enteritis.